Literature DB >> 32868339

Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes.

Lue Ping Zhao1, George K Papadopoulos2, William W Kwok3, Antonis K Moustakas4, George P Bondinas5, Annelie Carlsson6, Helena Elding Larsson7, Johnny Ludvigsson8, Claude Marcus9, Ulf Samuelsson8, Ruihan Wang10, Chul-Woo Pyo10, Wyatt C Nelson10, Daniel E Geraghty10, Åke Lernmark11.   

Abstract

HLA-DQA1 and -DQB1 genes have significant and potentially causal associations with autoimmune type 1 diabetes (T1D). To follow up on the earlier analysis on high-risk HLA-DQ2.5 and DQ8.1, the current analysis uncovers seven residues (αa1, α157, α196, β9, β30, β57, and β70) that are resistant to T1D among subjects with DQ4-, 5-, 6-, and 7-resistant DQ haplotypes. These 7 residues form 13 common motifs: 6 motifs are significantly resistant, 6 motifs have modest or no associations (P values >0.05), and 1 motif has 7 copies observed among control subjects only. The motifs "DAAFYDG," "DAAYHDG," and "DAAYYDR" have significant resistance to T1D (odds ratios [ORs] 0.03, 0.25, and 0.18; P = 6.11 × 10-24, 3.54 × 10-15, and 1.03 × 10-21, respectively). Remarkably, a change of a single residue from the motif "DAAYHDG" to "DAAYHSG" (D to S at β57) alters the resistance potential, from resistant motif (OR 0.15; P = 3.54 × 10-15) to a neutral motif (P = 0.183), the change of which was significant (Fisher P value = 0.0065). The extended set of linked residues associated with T1D resistance and unique to each cluster of HLA-DQ haplotypes represents facets of all known features and functions of these molecules: antigenic peptide binding, peptide-MHC class II complex stability, β167-169 RGD loop, T-cell receptor binding, formation of homodimer of α-β heterodimers, and cholesterol binding in the cell membrane rafts. Identification of these residues is a novel understanding of resistant DQ associations with T1D. Our analyses endow potential molecular approaches to identify immunological mechanisms that control disease susceptibility or resistance to provide novel targets for immunotherapeutic strategies.
© 2020 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32868339      PMCID: PMC7576571          DOI: 10.2337/db20-0374

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  70 in total

1.  The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity.

Authors:  Kenji Yoshida; Adam L Corper; Rana Herro; Bana Jabri; Ian A Wilson; Luc Teyton
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

2.  Genetic Variation Within the HLA-DRA1 Gene Modulates Susceptibility to Type 1 Diabetes in HLA-DR3 Homozygotes.

Authors:  Özkan Aydemir; Janelle A Noble; Jeffrey A Bailey; Åke Lernmark; Patrick Marsh; Agnes Andersson Svärd; Frank Bearoff; Elizabeth P Blankenhorn; John P Mordes
Journal:  Diabetes       Date:  2019-04-08       Impact factor: 9.461

Review 3.  T cell antigen receptor recognition of antigen-presenting molecules.

Authors:  Jamie Rossjohn; Stephanie Gras; John J Miles; Stephen J Turner; Dale I Godfrey; James McCluskey
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

4.  Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families.

Authors:  Patrick Concannon; Henry A Erlich; Cecile Julier; Grant Morahan; Jørn Nerup; Flemming Pociot; John A Todd; Stephen S Rich
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

5.  DRB4*01:01 Has a Distinct Motif and Presents a Proinsulin Epitope That Is Recognized in Subjects with Type 1 Diabetes.

Authors:  Eddie A James; Laurel Gillette; Ivana Durinovic-Bello; Cate Speake; George P Bondinas; Antonis K Moustakas; Carla J Greenbaum; George K Papadopoulos; William W Kwok
Journal:  J Immunol       Date:  2018-11-19       Impact factor: 5.422

6.  Diverse T Cell Receptor Gene Usage in HLA-DQ8-Associated Celiac Disease Converges into a Consensus Binding Solution.

Authors:  Jan Petersen; Yvonne Kooy-Winkelaar; Khai Lee Loh; Mai Tran; Jeroen van Bergen; Frits Koning; Jamie Rossjohn; Hugh H Reid
Journal:  Structure       Date:  2016-08-25       Impact factor: 5.006

7.  Polymorphic structural features of modelled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM.

Authors:  J Routsias; G K Papadopoulos
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

8.  Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden.

Authors:  A Carlsson; I Kockum; B Lindblad; L Engleson; A Nilsson; G Forsander; A-K Karlsson; A Kernell; J Ludvigsson; C Marcus; I Zachrisson; S-A Ivarsson; A Lernmark
Journal:  Int J Obes (Lond)       Date:  2011-06-28       Impact factor: 5.095

9.  Eleven Amino Acids of HLA-DRB1 and Fifteen Amino Acids of HLA-DRB3, 4, and 5 Include Potentially Causal Residues Responsible for the Risk of Childhood Type 1 Diabetes.

Authors:  Lue Ping Zhao; George K Papadopoulos; William W Kwok; Bryan Xu; Matthew Kong; Antonis K Moustakas; George P Bondinas; Annelie Carlsson; Helena Elding-Larsson; Johnny Ludvigsson; Claude Marcus; Martina Persson; Ulf Samuelsson; Ruihan Wang; Chul-Woo Pyo; Wyatt C Nelson; Daniel E Geraghty; Åke Lernmark
Journal:  Diabetes       Date:  2019-05-24       Impact factor: 9.461

10.  Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children.

Authors:  Lue Ping Zhao; George K Papadopoulos; William W Kwok; Antonis K Moustakas; George P Bondinas; Helena Elding Larsson; Johnny Ludvigsson; Claude Marcus; Ulf Samuelsson; Ruihan Wang; Chul-Woo Pyo; Wyatt C Nelson; Daniel E Geraghty; Åke Lernmark
Journal:  Diabetes       Date:  2020-04-03       Impact factor: 9.461

View more
  1 in total

1.  Association of HLA-DQ Heterodimer Residues -18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial-Type 1.

Authors:  Lue Ping Zhao; Jay Skyler; George K Papadopoulos; Alberto Pugliese; James Antonio Najera; George P Bondinas; Antonis K Moustakas; Ruihan Wang; Chul-Woo Pyo; Wyatt C Nelson; Daniel E Geraghty; Åke Lernmark
Journal:  Diabetes Care       Date:  2022-07-07       Impact factor: 17.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.